Ocular surface control
starts with Lacrifill®

A unique cross-linked hyaluronic acid canalicular gel designed for lacrimal occlusion.1 Lacrifill puts you in control, offering rapid relief and long-lasting dry eye treatment without relying on patient compliance.2,7

Ocular surface control
starts with Lacrifill®

A unique cross-linked hyaluronic acid canalicular gel designed for lacrimal occlusion.1 Lacrifill puts you in control, offering rapid relief and long-lasting dry eye treatment without relying on patient compliance.2,7

lacrifill eu box UK DK FI SE NO 1 scaled | Lacrifill

Lacrifill: cross-linked hyaluronic acid canalicular gel

Lacrifill is a preservative free, cross-linked hyaluronic acid canalicular gel for lacrimal occlusion.1 Each administration of Lacrifill is proven to provide sustained dry eye relief for up to 6 months.2

Lacrifill conforms to each patient’s unique canalicular anatomy, eliminating the need for sizing and providing a simple, one-size-fits-all solution. Lacrifill is designed to support both patient comfort and long-lasting efficacy.1,2

Ready for your practice

Lacrifill® comes ready for use in a pre-filled syringe with 0.6ml of gel, containing enough gel to fully fill both inferior canaliculi of a single patient.1 Lacrifill can be administered by any trained eyecare professional such as ophthalmologists and advanced optometrists in a standard practice setting1. Lacrifill has a shelf-life of 3 years and should be stored at room temperature (5-25°C).1

Still Image | Lacrifill

Register your interest in Lacrifill canalicular gel

If you would like to receive further information about Lacrifill® or training on Lacrifill, please fill out this form.

Peri op osc matters | Lacrifill

Why peri-operative ocular surface control matters

Dry eye disease can compromise preoperative measurements and surgical planning, increasing the risk of refractive error.3,4 While most patients with pre-existing dry eye are asymptomatic before surgery, 87% become symptomatic after it.5

Managing the ocular surface perioperatively can help maximise surgical outcomes and avoid unsatisfactory vision, worsening symptoms, and patient dissatisfaction.6

Proven to relieve the signs and symptoms of dry eye for 6 months

The efficacy and safety of Lacrifill was evaluated over 6 months in a randomised, double-masked clinical trial.2

From baseline to 6 months, Lacrifill® improved:2

  • Tear quantity
  • Symptoms of dry eye
  • Ocular surface health
  • Tear stability
| Lacrifill

Latest Lacrifill® Resources

  • onlineweb | Lacrifill

    Videos

    On Demand Webinar – What your patients expect and what their ocular surface demands

  • lacrifill package 2 | Lacrifill

    Product materials

    Receive more information

  • thumb | Lacrifill

    Product materials, Videos

    Administration Training